ERBB2 and carcinoma: Others demonstrated a differential distribution of certain genes between H2L and HER2-negative carcinomas, with a significant upregulation of luminal genes associated with a downregulation of basal-like proliferation genes in H2L carcinomas compared to HER2-negative carcinomas [4], maintained in HR+ carcinomas.